Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mamta Jagani"'
Publikováno v:
Pediatrics. 138(6)
Pediatric pharmacists are constantly faced with the challenges of supporting children and caregivers for whom the difficulties of swallowing medicines can be a daily struggle. Most medicines are only available as tablets and capsules, and where liqui
Autor:
Paul Veys, Austen Worth, Persis Amrolia, Robert Chiesa, Nicholas Goulden, Rachel Conyers, Jonathon Cohen, Mamta Jagani, K Rao
Publikováno v:
British Journal of Haematology. 155:377-385
This study investigated the efficacy of a pre-emptive strategy based on the combination of Epstein-Barr virus (EBV) viraemia and poor T cell reconstitution in preventing post-transplant lymphoproliferative disease (PTLD) following T cell depleted ste
Publikováno v:
Journal of Pediatric Hematology/Oncology. 31:456-461
Patients with steroid-refractory acute graft-versus-host disease (aGVHD) have a high mortality due to infections and progressive aGVHD. We investigated the combined use of 2 monoclonal antibodies (Mabs), daclizumab and infliximab in steroid-refractor
Autor:
Waseem Qasim, Prashant Hiwarkar, Persis Amrolia, Judith Breuer, Hubert B. Gaspar, N. Bennett-Rees, K Rao, Graham Davies, Robert Chiesa, C Cale, Paul Veys, Nick Goulden, Kimberly Gilmour, Mamta Jagani
Publikováno v:
Bone marrow transplantation. 48(6)
While pre-emptive rituximab therapy for EBV has substantially reduced the incidence of post-transplant lymphoproliferative disorder, following allogeneic haematopoietic SCT (HSCT), cytomegalovirus (CMV) and adenovirus (ADV) still contribute to signif
Autor:
Persis Amrolia, Robert Wynn, Brigit Greystoke, Sonia Bonanomi, Paul Veys, Maged I. Gharib, Nicholas Goulden, Mamta Jagani, Paru Naik, Mary Coussons, Tasneem Khalid, K Rao, Trevor F. Carr
Publikováno v:
British journal of haematology. 142(2)
Treosulfan is an immuno-suppressive and myeloablative alkylating agent that has been introduced as a conditioning agent in stem cell transplantation (SCT). Most studies have been performed in adult patients with malignancy where a low incidence of re